Prominent oncogenic pathways and related genes, such as PI3K/AKT, KRAS, MAPK, Wnt, β-catenin, BRCA2, ESR1 and P-cadherin, are commonly up-regulated while representative tumor suppressive pathways, such as p53, p16/INK4A, PTEN and E-cadherin, are down-regulated in human and canine breast cancer [19,21,22,23,24,25]. This evidence concerns the gene CDKN2A and neoplasm.